Health Care: Drugs

Vertex Pharmaceuticals Inc (VRTX: NASDAQ)

$133.06 n/a | n/a%
11/27/15 - 12:59 PM ET
Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -742.75M -687.55M -51.13M 41.18M
Operating Gains/Losses 0.00 0.00 390.00K 16.86M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 7.43M 53.36M 39.91M -170.61M
(Increase) Decrease in Inventories -16.47M 7.14M -29.93M -111.39M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 25.05M -49.23M 14.89M 37.47M
(Decrease) Increase In Other Current Liabilities 14.23M 48.75M 17.87M 125.61M
(Increase) Decrease In Other Working Capital -25.53M -53.01M -44.28M -72.44M
Other Non-Cash Items 177.07M 877.72M 257.52M 232.81M
Net Cash From Continuing Operations -513.20M -51.57M 267.84M 143.74M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -513.20M -51.57M 267.84M 143.74M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 1.56B 2.35B 1.37B 1.02B
Purchases of Property, Plant & Equipment -61.20M -51.39M -71.14M -94.59M
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments -1.42B -2.41B -1.71B -721.54M
Other Cash from Investing Activities 1.39M 61.39M -16.77M 12.51M
Cash Provided by Financing Activities
Net Cash From Investing Activities 73.96M -54.13M -425.82M 212.41M
Issuance of Debt 294.24M 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 274.62M 265.88M 191.72M 124.86M
Repayment of Long-Term Debt -81.69M -83.74M -21.49M -250.00M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 10.21M -1.25M 1.97M 900.00K
Net Cash From Financing Activities 497.38M 180.88M 172.20M -124.24M
Effect of Exchange Rate Changes -2.18M 4.71M -141.00K 214.00K
Net Change in Cash & Cash Equivalents 55.96M 79.89M 14.09M 232.12M

Portfolios with VRTX

Latest VRTX Headlines from TheStreet

More Financial News for VRTX

Press Releases for VRTX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter